Crossmark

Amyloid-independent pathogenesis for Alzheimer’s disease: implications for drug design

Crossref DOI link: https://doi.org/10.1007/s00044-024-03261-9

Published Online: 2024-06-18

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wolfe, Michael S. https://orcid.org/0000-0002-5721-9092
License Information

Text and Data Mining valid from 2024-06-18

Version of Record valid from 2024-06-18
More Information

Article History

Received: 25 April 2024

Accepted: 8 June 2024

First Online: 18 June 2024

Compliance with ethical standards

:

: The author declares no competing interests.